Desensitization to acetylsalicylic acid in patients undergoing percutaneous coronary intervention. Experience in a tertiary center.

Antiplatelet agents, which have been reviewed recently in the vista Española de Cardiologı́a, and acetylsalicylic acid in particular, e essential for the treatment of ischemic heart disease, especially the secondary prevention setting. Hypersensitivity reactions acetylsalicylic acid, whether allergic (IgE-mediated) or eudoallergic (caused by a nonimmunologic mechanism) should t be considered as an absolute contraindication because de tio in in ea fo lic un pr th